Andrea Bacigalupo Selected Research

Tretinoin (Retinoic Acid)

1/2023	Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All-Trans Retinoic Acid: A Monocentric Experience.
1/2019	Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid.
11/2012	Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia in the ATRA and ATO era.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea Bacigalupo Research Topics

Disease

46	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2024 - 07/2002
40	Aplastic Anemia (Anemia, Hypoplastic) 01/2023 - 12/2002
27	Leukemia 10/2020 - 08/2002
24	Bronchiolitis Obliterans Syndrome 12/2022 - 06/2002
23	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2023 - 11/2002
16	Primary Myelofibrosis (Myelosclerosis) 03/2024 - 05/2005
14	Neoplasms (Cancer) 11/2023 - 08/2003
14	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020 - 06/2002
10	Hematologic Neoplasms (Hematological Malignancy) 03/2024 - 06/2002
9	Infections 01/2021 - 12/2002
6	Multiple Myeloma 06/2013 - 09/2003
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021 - 07/2002
5	Hodgkin Disease (Hodgkin's Disease) 11/2020 - 02/2009
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2023 - 03/2016
4	idiopathic Aplastic anemia 01/2022 - 08/2005
4	Mycoses (Diseases, Fungus) 11/2020 - 10/2009
4	Neutropenia 01/2018 - 12/2002
3	Splenomegaly 12/2023 - 01/2018
3	POEMS Syndrome (Syndrome, POEMS) 08/2023 - 04/2018
3	Acute Promyelocytic Leukemia 01/2023 - 11/2012
3	Polycythemia Vera 12/2022 - 08/2014
3	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2020 - 06/2010
3	Aspergillosis 12/2013 - 04/2002
2	Hemorrhagic Cystitis 01/2024 - 06/2022
2	COVID-19 08/2023 - 01/2021
2	Essential Thrombocythemia 12/2022 - 08/2014
2	Residual Neoplasm 11/2021 - 01/2016
2	Viremia 10/2020 - 12/2018
2	Fibrosis (Cirrhosis) 01/2019 - 07/2007
2	Cytomegalovirus Infections (Inclusion Disease) 12/2018 - 11/2012
2	Myeloproliferative Disorders (Myeloproliferative Disorder) 01/2018 - 08/2014
2	Sepsis (Septicemia) 01/2018 - 04/2007
2	Anemia 01/2018 - 07/2009
2	Disease Progression 07/2009 - 02/2009
1	Depressive Disorder (Melancholia) 01/2023
1	Cytokine Release Syndrome 01/2023
1	Body Weight (Weight, Body) 01/2023
1	cell-associated neurotoxicity 01/2023
1	Malnutrition (Nutritional Deficiencies) 08/2022
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 06/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Bone Marrow Failure Disorders 10/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2021

Drug/Important Bio-Agent (IBA)

26	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2024 - 06/2010
21	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2023 - 09/2002
18	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2023 - 08/2003
12	fludarabineIBA 01/2021 - 04/2007
9	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2023 - 06/2002
7	SteroidsIBA 02/2020 - 05/2006
5	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 01/2020 - 04/2007
5	thymoglobulin FDA Link 01/2020 - 05/2006
5	Busulfan (Busulfex)FDA Link 01/2020 - 09/2008
5	HLA Antigens (Human Leukocyte Antigens)IBA 04/2016 - 08/2006
4	GlobulinsIBA 02/2020 - 09/2004
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2023 - 11/2012
3	Arsenic Trioxide (Trisenox)FDA Link 01/2023 - 11/2012
3	Methotrexate (Mexate)FDA LinkGeneric 10/2020 - 08/2003
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 10/2020 - 04/2007
3	AntibodiesIBA 02/2015 - 12/2006
3	galactomannanIBA 12/2013 - 04/2002
3	Filgrastim (Neupogen)FDA Link 12/2008 - 08/2002
3	LigandsIBA 08/2006 - 08/2003
2	Tyrosine Kinase InhibitorsIBA 11/2023 - 09/2013
2	ruxolitinibIBA 01/2023 - 01/2018
2	Thomsen-Friedenreich antibodiesIBA 02/2020 - 01/2020
2	Foscarnet FDA LinkGeneric 12/2018 - 11/2012
2	Alemtuzumab (Campath)FDA Link 11/2018 - 03/2010
2	AntigensIBA 01/2018 - 04/2002
2	Hemoglobins (Hemoglobin)IBA 01/2018 - 11/2012
2	Methylprednisolone FDA LinkGeneric 12/2017 - 05/2006
2	HLA-A Antigens (HLA-A)IBA 04/2017 - 08/2006
2	Prostaglandins FIBA 09/2014 - 07/2006
2	Imatinib Mesylate (Gleevec)FDA Link 12/2013 - 07/2009
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 07/2009 - 07/2007
2	Immunoglobulin G (IgG)IBA 07/2009 - 07/2007
1	letermovirIBA 01/2024
1	Janus Kinase InhibitorsIBA 12/2023
1	Histocompatibility Antigens (Histocompatibility Antigen)IBA 11/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	Fibrinogen (Factor I)FDA Link 01/2023
1	fibrin fragment D (D-dimer)IBA 01/2023
1	InterferonsIBA 12/2022
1	Hydroxyurea (Hydrea)FDA LinkGeneric 12/2022
1	ibrutinibIBA 04/2021

Therapy/Procedure

63	Transplantation 01/2023 - 06/2002
57	Stem Cell Transplantation 03/2024 - 06/2002
51	Hematopoietic Stem Cell Transplantation 01/2024 - 05/2005
21	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2023 - 06/2002
20	Therapeutics 03/2024 - 05/2005
9	Cell Transplantation 03/2024 - 04/2007
5	Haploidentical Transplantation 11/2020 - 04/2015
5	Drug Therapy (Chemotherapy) 01/2020 - 10/2004
4	Homologous Transplantation 01/2021 - 11/2002
3	Splenectomy 01/2019 - 03/2004
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 08/2023 - 04/2018
2	Immunotherapy 01/2021 - 01/2016
2	Hematopoietic Stem Cell Mobilization 12/2019 - 04/2018
2	Radiotherapy 01/2018 - 12/2008
2	Photopheresis 10/2013 - 10/2008
1	Treatment Delay 01/2022